Submit Deal

VALO THERAPEUTICS

HQ - Helsinki

Summary

Valo Therapeutics Oy (ValoTx) is an immunotherapy company developing tumor antigen-coated replication-competent viruses as therapeutic vaccines against cancer.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 16 M

Avg. Deal Size£ 16 M

Market Context

Senior Management

Vincenzo Cerullo
Co-founder
David Hinton
Chair
Matthew Vaughan
Business Operations Director

Sort

31 Jan 2025|Finland|Biotechnology

Target: VALO THERAPEUTICS

Bidder: INDACO VENTURE PARTNERS

6 Service Providers

3 Target | 3 Bidder

11 Dealmakers

8 Target | 3 Bidder

£ 16 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy